JavaScript is off. Please enable to view full site.

Trump treated with experimental antibody cocktail for COVID-19

Trump treated with experimental antibody cocktail for COVID-19

Saturday, October 03, 2020, 14:01 GMT+7
Trump treated with experimental antibody cocktail for COVID-19
The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. Photo: Reuters

President Donald Trump has been treated with an experimental antibody cocktail for COVID-19 and is moving to a military hospital as a precautionary measure, White House officials said on Friday.

The president’s physician, Dr. Sean Conley, said in a statement that Trump “remains fatigued but in good spirits” after receiving an intravenous dose of Regeneron Pharmaceuticals Inc’s dual antibody.

Trump was also taking immune system boosters zinc and vitamin D, aspirin, and other generic drugs.

Trump, 74, walked to a helicopter on Friday before being moved to a special suite at Walter Reed National Military Medical Center in Bethesda, Maryland, for the next few days.

Regeneron’s drug, REGN-COV2, is part of a class of experimental COVID-19 drugs known as monoclonal antibodies: manufactured copies of human antibodies to the virus that are being studied for use in patients with early illness.

Trump’s doctors “must be sufficiently concerned with what they are seeing that they decided to use an experimental medicine ... Experimental drugs are by definition risky,” said Dr. Edward Jones-Lopez, infectious disease specialist at the Keck School of Medicine of the University of Southern California in Los Angeles.

Antibodies are proteins made by the body’s immune system that latch onto and neutralize an invading virus.

Regeneron’s cocktail - which contains an antibody made by the company and a second isolated from humans who recovered from COVID-19 - is designed so that its two antibodies bind to the coronavirus’ spike protein, limiting the ability of viruses to escape.

“The trouble is we don’t have good treatments for people with mild COVID-19 ... I imagine that they are doing this because they hope this is relatively low risk,” said Dr. Rajesh Gandhi, an infectious disease physician at Massachusetts General Hospital in Boston.

U.S. President Donald Trump exits the Oval Office as he departs on campaign travel to Minnesota from the South Lawn at the White House in Washington, U.S., September 30, 2020. Picture taken September 30, 2020. Photo: Reuters

U.S. President Donald Trump exits the Oval Office as he departs on campaign travel to Minnesota from the South Lawn at the White House in Washington, U.S., September 30, 2020. Picture taken September 30, 2020. Photo: Reuters

Data so far is limited for COVID-19 antibodies, but U.S. infectious disease chief Dr. Anthony Fauci is among those saying the technology has promise.

Regeneron this week reported trial results showing that its drug improved symptoms in non-hospitalized COVID-19 patients, with no serious side effects, and said it planned to talk with the Food and Drug Administration (FDA) about an emergency use authorization.

Eli Lilly & Co has also announced encouraging early data from a trial of its coronavirus antibody, and said it is seeking emergency authorization from the FDA.

Shares of Regeneron rose about 3% in after hours trade, following the announcement that Trump was given the drug.

Trump is also taking the heartburn drug famotidine - often sold in the U.S. under the brand name Pepcid. Although the drug has not been shown to work against COVID-19, researchers are studying it as a possible treatment.

Zinc and vitamin D are believed to boost the immune system.

Melatonin is a hormone that helps to regulate daily body rhythms.

Trump has said in the past that he takes a daily low-dose aspirin, which is recommended for some adults at increased risk of heart attack or stroke.

Reuters

More

Read more

;

Photos

VIDEOS

Vietnamese woman gives unconditional love to hundreds of adopted children

Despite her own immense hardship, she has taken in and cared for hundreds of orphans over the past three decades.

Vietnam’s Mekong Delta celebrates spring with ‘hat boi’ performances

The art form is so popular that it attracts people from all ages in the Mekong Delta

Vietnamese youngster travels back in time with clay miniatures

Each work is a scene caught by Dung and kept in his memories through his journeys across Vietnam

Experience summer sand-boarding in Mui Ne

Sand-boarding, a popular activity amongst local children in the coastal tourism town of Mui Ne in south-central Vietnam, is attracting hundreds of tourists to the Red Sand Dunes

Latest news